Simtra BioPharma Solutions is a leading CDMO specializing in sterile fill/finish solutions. Founded in 2022 following the acquisition and rebranding of Baxter BioPharma Solutions, Simtra builds on decades of expertise to support biopharmaceutical and pharmaceutical companies. Headquartered in New Jersey with manufacturing facilities in Indiana and Germany, the company offers comprehensive CDMO services, including drug formulation, lyophilization, and sterile manufacturing, ensuring high-quality solutions for complex and high-value therapeutics.
